MyFinsight
Home
Blog
About
Maturities of
available-for-sale securities
$64,851K
(-9.32%↓ Y/Y)
something is missing
$9,986K
Proceeds from sales of
common stock, pursuant...
$160K
(10.34%↑ Y/Y)
Net cash used in
investing activities
$15,019K
(1254.42%↑ Y/Y)
Net cash provided by
financing activities
$147K
(-98.55%↓ Y/Y)
Canceled cashflow
$49,832K
Canceled cashflow
$9,999K
Net increase
(decrease) in cash and cash...
-$5,484K
(83.25%↑ Y/Y)
Canceled cashflow
$15,166K
Share-based compensation
$3,046K
(-32.33%↓ Y/Y)
Accrued personnel
expenses
$2,096K
(575.28%↑ Y/Y)
Depreciation and
amortization expense
$1,141K
(-22.12%↓ Y/Y)
Accounts payable and
accrued expenses
$632K
(113.90%↑ Y/Y)
Interest receivable
-$142K
(-149.65%↓ Y/Y)
Other noncurrent
liabilities
$70K
(-69.43%↓ Y/Y)
Other noncash income,
net
-$36K
(83.78%↑ Y/Y)
Purchases of
available-for-sale securities
$35,616K
(-46.92%↓ Y/Y)
Additions to property and
equipment
$14,195K
(149.82%↑ Y/Y)
Additions to other assets
$21K
(-53.33%↓ Y/Y)
Proceeds from sale of
common stock pursuant...
-$9,986K
(-200.00%↓ Y/Y)
Repayment of note payable
$13K
(-50.00%↓ Y/Y)
Net cash used in
operating activities
-$20,650K
(50.28%↑ Y/Y)
Canceled cashflow
$7,163K
Net loss
-$26,786K
(32.46%↑ Y/Y)
Net accretion of
discounts on...
-$661K
(62.55%↑ Y/Y)
Accounts receivable, net
$211K
(93.58%↑ Y/Y)
Prepaid expenses and
other current assets
$155K
(159.85%↑ Y/Y)
Back
Back
Cash Flow
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX)
source: myfinsight.com